Bonstein Sara
- SEC CIK
- 0001604019
In the past year, 4 open-market sale filings worth $2.13M and no purchases.
Current role at each company
- XLO Xilio Therapeutics, Inc.Directoras of Jun 12, 2026
- INSM INSMED IncChief Financial Officeras of Jun 5, 2026
- SCPH scPharmaceuticals Inc.Directoras of Oct 7, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.13M
- 4 filings
- Net
- −$2.13M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bonstein Sara as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INSM INSMED Inc
Chief Financial Officer22 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 (view filing) | Jun 3 | 2 days | Bonstein SaraChief Financial Officer | SSale | −2.40K | $102.27 | −$245.9K | −3.4%69.1K after | |
| May 15, 2026 (view filing) | May 13 | 2 days | Bonstein SaraChief Financial Officer | SSale | −8.27K | $116.18 | −$961.0K | −10.4%71.5K after | |
| Feb 4, 2026 (view filing) | Feb 3 | 1 day | Bonstein SaraChief Financial Officer | SSale | −748 | $156.34 | −$116.9K | −0.9%79.8K after | |
| Jan 8, 2026 (view filing) | Jan 6-8 | 2 days | Bonstein SaraChief Financial Officer | SSale | −4.64K | $174.22 | −$808.7K | −5.5%80.5K after | 3 lots |
| Jul 23, 2025 (view filing) | Jul 21 | 2 days | Bonstein SaraChief Financial Officer | SSale | −58.4K | $102.67 | −$6.00M | −44.3%73.5K after | 2 lots10b5-1 |
| Jul 9, 2025 (view filing) | Jul 7 | 2 days | Bonstein SaraChief Financial Officer | SSale | −57.8K | $95.86 | −$5.54M | −40.7%84.0K after | 2 lots10b5-1 |
| Jun 25, 2025 (view filing) | Jun 23 | 2 days | Bonstein SaraChief Financial Officer | SSale | −57.8K | $101.78 | −$5.88M | −38.2%93.5K after | 2 lots10b5-1 |
| Jun 12, 2025 (view filing) | Jun 10 | 2 days | Bonstein SaraChief Financial Officer | SSale | −57.8K | $89.12 | −$5.15M | −35.8%103.4K after | 6 lots10b5-1 |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Bonstein SaraChief Financial Officer | SSale | −1.58K | $71.50 | −$112.9K | −1.4%113.3K after | |
| May 15, 2025 (view filing) | May 13-14 | 2 days | Bonstein SaraChief Financial Officer | SSale | −10.5K | $67.47 | −$708.7K | −8.8%108.4K after | 2 lots |